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Introduction 
Delayed ischemic neurologic deficits sec-
ondary to vasospasm are a major cause of 
morbidity and mortality after subarachnoid 
hemorrhage (SAH) (1). The development of 
vasospasm can be recognized by neurologic 
deterioration in combination with radiologi-
cal techniques, such as conventional digital 
subtraction angiography (DSA), transcranial 
Doppler (TCD) ultrasound, positron emis-
sion tomography (PET), single-photon emis-
sion computer tomography (SPECT), and 
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single-slice perfusion computed tomographic 
technique (Xe-CT) (1–6). Two recent studies 
showed that perfusion CT (PCT) also re-
presents an accurate screening test in pa-
tients with suspected vasospasm, although 
further refinements are needed before routine 
recommendation (6,7). Once symptomatic 
vasospasm is evident (with focal  neuro-
logic signs), hemodynamic augmentation is 
widely employed, although definitive evi-
dence for this therapy is still lacking (1,8,9). 
Patients whose condition does not improve 
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with medical therapy undergo cerebral  angiography and 
transluminal angioplasty (1,10–12). Aggressive treatment of 
vasospasm is not without risk (1,8). Hemodynamic augmenta-
tion has a complication rate of 10–20% and balloon angioplasty 
may be complicated by vessel rupture, branch occlusion, and 
hemorrhagic infarction (1,8–11). Therefore, accurate monitor-
ing of treatment effects in patients with vasospasm after SAH 
is needed. We report the results of the use of PCT to evaluate 
the effect of transluminal percutaneous angioplasty and intra-
arterial papaverine in a patient with SAH and vasospasm-
 induced  ischemia.
Case Report
A 37-year-old woman was admitted with severe sudden 
headache, nausea, vomiting, and neck stiffness (Hunt & Hess 
grade II). Unenhanced CT showed SAH predominantly in the 
left Sylvian fissure and over the left lateral convexity (Fisher 
grade 3). DSA showed a left internal carotid artery tip aneurysm, 
which was treated with endovascular coil placement (Guglielmi 
Detachable Coils, Boston Scientific, Cork, Ireland). After the 
procedure she had mild headache and no neurological deficits. 
On the fourth day after coil placement, however, she de  veloped 
aphasia. TCD revealed severe vasospasm. Despite hemody-
namic augmentation and nimodipine, she remained symp-
tomatic and angioplasty was considered. PCT was performed 
6 days after coil placement to determine if there was brain tis-
sue at risk for cerebral infarction. Angioplasty was performed 
and PCT was repeated after angioplasty.
CT scanners with quadruple detector array were used be-
fore and after angioplasty. For PCT, we used a technique de-
scribed previously (3,4,7). In summary, after unenhanced CT 
of the brain, PCT was performed twice at two different levels, 
at the roof of the third ventricle and at the roof of the lateral 
ventricles. For each examination 40 mL of a nonionic contrast 
agent (iodixanol, Visipaque 320 mg of iodine per mL, GE 
Health, Cork, Ireland) were injected with a power injector into 
Fig. 1. PCT was performed to determine if the patient was at risk for cerebral infarction and whether transluminal angioplasty should be 
performed or not (A–C) and was repeated after angioplasty to monitor treatment effects on cerebral perfusion (D–F). (A) Preangioplasty 
PCT CBV map demonstrates increased CBV values in the left hemisphere, consistent with ischemia-related activation of cerebral autoregu-
lation (blue to red: CBV = 0 to 20 mL/100g). (B) Preangioplasty PCT MTT map demonstrates increased MTT values in the left hemisphere, 
consistent with ischemia-related activation of cerebral autoregulation (red to blue: MTT = 0 to 15 seconds). (C) Preangioplasty PCT CBF 
map demonstrates normal to decreased CBF values in the left hemisphere (blue to red: CBF = 0 to 100 mL per 100 g and per minute). (D) 
Postangioplasty PCT CBV map demonstrates normalized CBV values in the left hemisphere, symmetric to the normal right side. (E) Post-
angioplasty perfusion CT MTT map demonstrates normalized MTT values in the left hemisphere, symmetric to the normal right side. (F) 
Postangioplasty PCT CBF map demonstrates normalized CBF values in the left hemisphere, symmetric to the normal right side.42    Majoie et al.
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a cubital vein at a rate of 4 mL/second. At 7 seconds after initi-
ation of the injection, a continuous scan was started with the 
following parameters: 80 kV, 100 mA (Sensation 4) or 90 kV, 
120 mA (Mx8000), 4 × 5-mm collimation, 1 second per rotation 
for 46 seconds. The four 5-mm sections were reformatted into 
two 10-mm-thick sections. The overall dose required for PCT 
was 4.0–4.5 mSv. PCT data were analyzed with commercially 
available software developed by Wintermark et al. (14). Image-
postprocessing involved placement of the region of interest 
(ROI) in an input artery (anterior cerebral artery) and an input 
vein (torcular herophili or superior sagittal sinus) and subse-
quent generation of contrast-enhancement curves. The soft-
ware generated color-coded cerebral blood flow (CBF),   cerebral 
blood volume (CBV) and mean transit time (MTT) maps based 
on the CT time attenuation curves for each pixel. After large 
vessel removal, four circular ROIs of 1.5 cm in diameter were 
placed along the cortical mantle of each hemisphere in the 
middle cerebral artery (MCA) territory on the perfusion maps 
to generate quantitative data. CBF, CBV, and MTT values in 
the normal right hemisphere were compared with those of the 
affected left hemisphere.
Unenhanced CT revealed a small left insular infarct. PCT 
showed areas of normal or decreased CBF and a large area of 
increased CBV and MTT in the MCA territory of the left hemi-
sphere (Figure 1A–C), consistent with ischemia-related activa-
tion of autoregulation. The mean value of cortical CBF mea-
sured in the MCA territory of the right (normal) hemisphere 
was 77 mL per 100 g and per minute (range: 40–174). The mean 
value of cortical CBF in the left (affected) hemisphere was 31 
mL per 100 g and per min (range: 13–38). The mean value of 
cortical CBV measured in the right (normal) hemisphere was 
1.4 mL/100 g (range: 1.1–1.8). The mean value of cortical CBV 
in the left (affected) hemisphere was 4.7 mL/100 g (range 3.9–
6.0). The mean value of cortical MTT measured in the right 
(normal) hemisphere was 1.2 seconds (range 0.6–1.9). The 
mean value of cortical MTT in the left (affected) hemisphere 
was 9.6 seconds (range 6.7–19.0).
On the same day as the PCT, angioplasty was performed 
under general anesthesia with full heparinization via a trans-
femoral approach using an over the wire (Transend 0.010 in, 
Target Therapeutics/Boston Scientific, Boston, MA) silicone 
balloon microcatheter (Sentry, Target Therapeutics/Boston 
Scientific, Fremont, CA), according to a technique described 
previously (11,15). Before angioplasty, DSA showed severe 
  vasospasm of the M1 segment of the left MCA and of the 
 proximal left M2 segments (Figure 2A). After angioplasty of 
the M1 segment of the left MCA a good angiographic result 
was obtained (Figure 2B). In addition, 150 mg of papaverine 
Fig. 2. DSA images in a 37-year-old woman who developed progressive aphasia 1 day after coiling of a ruptured left internal carotid artery-
tip aneurysm, despite optimal medical treatment. Transluminal balloon angioplasty was performed to treat the vasospasm. (A) Preangioplasty 
DSA demonstrates severe vasospasm in the M1 and M2 segments of left MCA. (B) Postangioplasty DSA shows return to normal caliber of 
the M1-segment of the left MCA.Neurocritical Care ♦ Volume 6, 2007
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(papaverine hydrochloride, Eli Lilly and Co., Indianapolis, IN) 
was infused via a microcatheter in the left MCA to treat spasm 
of the proximal M2 segments. Within 2 days, her aphasia dis-
appeared. PCT was repeated and showed symmetric, normal-
ized CBV, CBF, and MTT values (Figure 1D–F).
Case Discussion
This case illustrates the value of PCT in demonstrating the 
effect of transluminal balloon angioplasty on cerebral perfu-
sion in a patient with vasospasm after SAH. Before angio-
plasty, decreased to normal CBF and increased CBV and MTT 
were identified in the left MCA territory, indicating tissue at 
risk for cerebral infarction with intact autoregulation. After an-
gioplasty, perfusion parameters returned to normal values and 
were symmetric.
Cerebral vasospasm is a frequent complication in patients 
with aneurysmal SAH (1). In 50% of cases it is manifested by 
delayed neurologic deficits related to ischemia, with progres-
sion to infarction in approximately one-half of the symptomatic 
cases (1,8). Angioplasty for vasospasm may significantly reduce 
morbidity and mortality if performed early after medical ther-
apy has failed (1,10). It is, albeit rarely, also associated with se-
vere complications, such as vessel rupture, and should there-
fore only be used in those patients in whom vasospasm causes 
cerebral ischemia (1,8). Because delayed neurologic deficits fol-
lowing SAH may have different causes, including hydrocepha-
lus, hemorrhage, edema, metabolic factors, and ischemia (12), it 
is important to identify those patients with vasospasm who 
most likely will benefit from angioplasty. Although TCD may 
aid in the determination of vasospasm, it does not necessarily 
assist in the identification of ischemia (12). SPECT (2), Xe-CT 
(3), and PET (4,5) are reliable methods for the determination of 
cerebral perfusion, but these techniques are cumbersome and 
not widely available. PCT can be combined with unenhanced 
CT, which is routinely performed for follow-up of patients with 
SAH (7). Nabavi et al. used this technique for monitoring 
 cerebral perfusion after aneurysmal SAH (6). They found signi-
ficant differences in CBF and CBV between patients with signif-
icant and absent or minor vasospasm and between patients 
with and without a presumed vasospasm-related infarct. They 
could not, however, define a PCT-threshold for cerebral infarct 
by using PCT, because of the use of relatively large ROIs, caus-
ing volume averaging with normal and ischemic tissue (6,16).
The findings of the current report are consistent with  results 
described by Grubb et al. (17). The system of autoregulation is 
reflected by PCT findings in patients with cerebral ischemia 
(18). A mild reduction in cerebral perfusion pressure is associ-
ated with a compensatory dilatation of cerebral blood vessels. 
Under these circumstances, measurements of CBF remain 
within normal range, while those of CBV and MTT increase. As 
perfusion pressure falls, normal CBF cannot be maintained, 
despite further vasodilatation (oligemia or misery perfusion). 
When perfusion pressure falls below a threshold of approxi-
mately 20 mL per 100 g and per minute, cerebral metabolism is 
severely impaired (ischemia). The development of subsequent 
irreversible damage (infarction) is not only   dependent on the 
absolute perfusion value but also on the time the tissue has 
been ischemic. Irreversible damage is associated with loss of 
autoregulatory vasodilatation and therefore reduced CBV (18). 
PCT may also be valuable in detecting   subclinical ischemia, 
i.e., areas of vasospasm which are still asymptomatic owing to 
intact autoregulation but may become symptomatic over time. 
Further research is warranted to determine if angioplasty of 
spastic vessels supplying these areas may improve outcome of 
patients with SAH.
PCT has several limitations, including restricted anatomic 
coverage and lack of full validation of its accuracy, reliability, 
and reproducibility of quantitative results (7,16,19,20). With 
our multislice CT scanner, we were able to use a collimation of 
4 × 5 mm and to obtain 2 × 10 mm reconstructed slices. By per-
forming PCT at two different levels we could obtain 4 cm brain 
coverage. With 16-, 32- and 64-slice CT scanners, a larger brain 
coverage will be possible. Quantitation is strongly dependent 
on the choice of the venous ROI location (19,20). Different 
ROI locations within the same vein may result in significantly 
different CBV and CBF values (19). The venous ROI with the 
greatest peak enhancement value should be chosen, as is done 
in the software used in this study to limit variability and in-
crease quality of PCT images (19). With proper ROI selections 
a good correlation between quantitative PCT maps and 
xenon-CT and positron emission tomography (PET) studies 
was found, as described in previous reports (3,5).
This case illustrates the value of PCT for monitoring treat-
ment effects in patients with symptomatic vasospasm. This 
minimally invasive technique is widely available and requires 
only a modest radiation dose.
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